Neuronetics
Manufacturing · Pennsylvania, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
3222 Phoenixville Pike, Malvern, Pennsyl...Phone Number
(877) 600-7555Website
www.neurostar.comRevenue
$155.1 MillionStock Symbol
STIMIndustry
About Neuronetics
Neuronetics is a leading provider of transcranial magnetic stimulation (TMS) therapy, specifically the NeuroStar Advanced Therapy System, designed to treat major depressive disorder (MDD) and associated anxiety symptoms in adults and adolescents. The company focuses on delivering non-drug, non-invasive treatment options backed by extensive clinical evidence, aiming to improve the quality of life for individuals suffering from psychiatric disorders. Neuronetics serves a broad audience, including over 21 million adults in the U.S. with MDD, and is committed to supporting healthcare practices with exceptional customer service and ongoing support. With a mission to transform neurohealth, Neuronetics is dedicated to expanding its capabilities and indications for treatment.Explore more
SIC Code 38,384NAICS Code 33,334Ticker NASDAQ: STIMShow moreNeuronetics Org Chart
Compare Similar Companies to Neuronetics
Compare insights from companies similar to Neuronetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neuronetics Tech Stack
A closer look at the technologies used by Neuronetics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuronetics
Sign Up For FreeTo access detailed company insights
Neuronetics is a leading provider of transcranial magnetic stimulation (TMS) therapy, specifically the NeuroStar Advanced Therapy System, designed to treat major depressive disorder (MDD) and associated anxiety symptoms in adults and adolescents. The company focuses on delivering non-drug, non-invasive treatment options backed by extensive clinical... Read More